Jane Street’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$92.8M Buy
390,452
+372,083
+2,026% +$77.3M 0.01% 984
2026
Q1
$3.88M Sell
18,369
-433,810
-96% -$93.4M ﹤0.01% 3910
2025
Q4
$92.9M Buy
452,179
+437,514
+2,983% +$82.3M 0.01% 617
2025
Q3
$2.3M Sell
14,665
-75,643
-84% -$11.7M ﹤0.01% 4668
2025
Q2
$15.2M Sell
90,308
-31,592
-26% -$4.69M ﹤0.01% 1716
2025
Q1
$16.8M Sell
121,900
-360,699
-75% -$46M ﹤0.01% 1452
2024
Q4
$57.1M Buy
482,599
+254,954
+112% +$29.8M 0.01% 633
2024
Q3
$25.2M Sell
227,645
-65,609
-22% -$6.86M 0.01% 1072
2024
Q2
$28.8M Buy
293,254
+214,195
+271% +$21.8M 0.01% 1016
2024
Q1
$8.85M Sell
79,059
-167,508
-68% -$18.1M ﹤0.01% 1947
2023
Q4
$24.9M Sell
246,567
-19,986
-7% -$1.98M 0.01% 1094
2023
Q3
$23.1M Buy
266,553
+20,884
+9% +$1.89M 0.01% 990
2023
Q2
$23.2M Buy
245,669
+47,841
+24% +$4.04M 0.01% 1077
2023
Q1
$14.9M Buy
197,828
+158,959
+409% +$12M 0.01% 1237
2022
Q4
$2.99M Sell
38,869
-17,976
-32% -$1.37M ﹤0.01% 3232
2022
Q3
$3.79M Sell
56,845
-92,179
-62% -$5.84M ﹤0.01% 3065
2022
Q2
$7.79M Sell
149,024
-70,793
-32% -$4.02M ﹤0.01% 2044
2022
Q1
$12.5M Buy
219,817
+155,116
+240% +$8.31M ﹤0.01% 1714
2021
Q4
$3.33M Sell
64,701
-35,956
-36% -$1.76M ﹤0.01% 3521
2021
Q3
$4.98M Sell
100,657
-162,807
-62% -$8.83M ﹤0.01% 2740
2021
Q2
$15M Buy
263,464
+196,208
+292% +$11.5M 0.01% 1323
2021
Q1
$4.09M Buy
67,256
+23,879
+55% +$1.32M ﹤0.01% 2707
2020
Q4
$2.32M Sell
43,377
-7,628
-15% -$396K ﹤0.01% 3233
2020
Q3
$2.4M Buy
51,005
+24,149
+90% +$1.24M ﹤0.01% 2771
2020
Q2
$1.4M Buy
26,856
+2,036
+8% +$105K ﹤0.01% 3577
2020
Q1
$1.19M Sell
24,820
-53,334
-68% -$2.77M ﹤0.01% 2590
2019
Q4
$3.95M Buy
78,154
+58,632
+300% +$3.03M 0.01% 1271
2019
Q3
$921K Buy
19,522
+11,229
+135% +$513K ﹤0.01% 2729
2019
Q2
$391K Sell
8,293
-5,491
-40% -$253K ﹤0.01% 3887
2019
Q1
$663K Sell
13,784
-18,985
-58% -$951K ﹤0.01% 3326
2018
Q4
$1.46M Buy
32,769
+20,061
+158% +$1.05M ﹤0.01% 2067
2018
Q3
$686K Sell
12,708
-25,087
-66% -$1.28M ﹤0.01% 3231
2018
Q2
$1.85M Buy
37,795
+28,850
+323% +$1.64M ﹤0.01% 2027
2018
Q1
$561K Sell
8,945
-68,366
-88% -$4.69M ﹤0.01% 3364
2017
Q4
$4.74M Sell
77,311
-65,971
-46% -$4.08M 0.01% 918
2017
Q3
$9.59M Buy
143,282
+135,033
+1,637% +$9.55M 0.03% 537
2017
Q2
$643K Sell
8,249
-4,070
-33% -$307K ﹤0.01% 2709
2017
Q1
$1M Sell
12,319
-88,707
-88% -$6.98M ﹤0.01% 2070
2016
Q4
$7.27M Buy
+101,026
New +$7.3M 0.03% 492
2016
Q3
Sell
-4,431
Closed -$358K 4004
2016
Q2
$346K Buy
+4,431
New +$353K ﹤0.01% 3156
2016
Q1
Sell
-6,615
Closed -$538K 4074
2015
Q4
$591K Sell
6,615
-1,659
-20% -$141K ﹤0.01% 2300
2015
Q3
$636K Buy
8,274
+274
+3% +$22.9K ﹤0.01% 2062
2015
Q2
$669K Sell
8,000
-7,599
-49% -$671K ﹤0.01% 1990
2015
Q1
$1.41M Buy
+15,599
New +$1.34M 0.01% 1104
2014
Q4
Sell
-6,203
Closed -$465K 2502
2014
Q3
$465K Buy
+6,203
New +$451K ﹤0.01% 1497
2014
Q2
Sell
-7,626
Closed -$534K 2576
2014
Q1
$534K Sell
7,626
-406
-5% -$28.2K 0.01% 1513
2013
Q4
$536K Buy
+8,032
New +$491K 0.01% 1184

Other funds holding CAH

Jane Street's CAH Position: Q2 2026 in Review

Jane Street increased its Cardinal Health (CAH) stake by 2,026% in Q2 2026, buying an estimated $77.3M and bringing the position to 390,452 shares worth $92.8M. The position accounts for 0.01% of the portfolio, ranked #984.

Jane Street first reported a position in CAH in Q4 2013 and has held it in 47 quarters since. The position peaked at $92.9M in Q4 2025. 1,499 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Jane Street held 390,452 shares of Cardinal Health worth $92.8M as of Q2 2026.
  • Jane Street bought 372,083 Cardinal Health shares in Q2 2026, an estimated $77.3M.
  • Cardinal Health made up 0.01% of Jane Street's portfolio in Q2 2026, its #984 holding.
  • Jane Street first reported a position in Cardinal Health in Q4 2013 and has held it in 47 quarters since.
  • Jane Street's Cardinal Health position peaked at $92.9M in Q4 2025.
  • 1,499 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.